Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Credit strategies dominate Lyxor hedge fund indices

Thursday, November 08, 2012

Stefan Keller
Opalesque Industry Update - Nine Lyxor Strategy Indices out of 14 ended the month in positive territory, led by the Lyxor Long/Short Credit Arbitrage Index (+1.7%), the Convertible Arbitrage Index (+0.5%), and the Distressed Index (+0.6%). The Lyxor Hedge Fund Index declined 0.6% in October (+1.6% in 2012 to date). Earnings season dominated news flow during the month of October. Earnings, as usual, generally beat expectations, but revenues and forward guidance disappointed investors. Fundamental news therefore drove most stock returns more than rumors about political deals did. Markets turned more pessimistic on growth mid-month and declined, but European equity markets managed to hold onto gains even as US markets ended in the red.

The dispersion among stocks and corporate bonds meant that hedge fund managers had the environment in which stock or credit selection skill was rewarded (i.e., alpha was possible). Beta management mattered greatly, though, as too much beta easily swamped alpha generation. Credit-oriented hedge funds continued to outshine funds in other strategies. The Lyxor L/S Credit Arbitrage Index gained 1.7% in October, yielding an 8.2% gain for 2012 thus far. The index has gained every month this year except for one (May). The active management of net exposure and the choice of short positions during a fundamentals-oriented month has been a major driver for Long/Short managers. A similar narrative played out for managers in the Lyxor Distressed Index (+0.6% this month and +6.3% year-to-date) and the Convertible Arbitrage Index (+0.5% this month and +3.6% year-to-date).

Stock selection mattered greatly for L/S Equity managers. Despite the down month for US equities, the Lyxor L/S Equity Long Bias Index gained 0.4% and the L/S Equity Market Neutral Index gained 0.7%. The L/S Equity Variable Bias Index declined 0.4% and the Statistical Arbitrage Index declined 1.5% as correlations rose toward month-end. Long positions in financials and in European equities were themes that paid off during the month.

The Merger Arbitrage Index declined 0.7% as spreads widened. Managers with higher risk budgets or exposures outside the US fell most. Political concerns (but not the usual European debt situation rumors) spiked a number of spreads wider. The Special Situations Index was flat on the month. Managed Futures continue to find little traction. The Lyxor Long- Term CTA Index declined 3.6% (-7.1% year-to-date) and the Short-term CTA Index fell 2.5% (-2.5% year-to-date). Managers were typically long bonds, equities, energy, and precious metals. Risk asset prices tumbled during the month and caused losses, but positions in potentially offsetting assets did not offset the losses.

Uncertainty regarding the outcome of the US elections has risen, leading managers to reduce risk somewhat in October. We expect hedge fund managers to express stronger convictions now says Stefan Keller, Head of Managed Account Platform Research & External Relations at Lyxor AM.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its